News | December 08, 2022
Cadila Pharmaceuticals signs IIF with Odisha Government
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
Acquisition expands Merck’s growing hematology portfolio
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
The company is making its entry into the Hyderabad market through its unique asset-light business model
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Funds raised will be used to develop technology and foster healthcare partnerships
Transformation to pure-play Innovative Medicines company nears completion
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Subscribe To Our Newsletter & Stay Updated
